Thursday, 25 February 2021

USIBC announces Vice Chairs for its 2021 Global Board of Directors

15 January 2021 | News

Effective immediately, Milind Pant, CEO, Amway; Kiran Mazumdar-Shaw, Executive Chairperson, Biocon; and Edward Knight, Vice Chair, Nasdaq will join the Board’s leadership team as Vice Chairs

Source credit: Shutterstock

Source credit: Shutterstock

The US Chamber of Commerce’s US-India Business Council (USIBC) announced Vice Chairs for its 2021 Global Board of Directors, strengthening its leadership team as the Council engages a new US administration and advocates for stronger US-India commercial ties in an increasingly complex world.

"I'm pleased to see the US-India Business Council elevate as Vice Chairs these captains of industry and forward-thinking business leaders,” said Vijay Advani, USIBC Board of Directors Chairman and Executive Chairman, Nuveen.

Effective immediately, Milind Pant, CEO, Amway; Kiran Mazumdar-Shaw, Executive Chairperson, Biocon; and Edward Knight, Vice Chair, Nasdaq will join the Board’s leadership team as Vice Chairs.

“I am honoured to step into this new role as a Vice Chair for the US-India Business Council’s Board of Directors,” said Milind Pant, CEO, Amway.

As Vice Chairs, Pant, Mazumdar-Shaw and Knight will work with USIBC President Nisha Biswal and the Council’s policy directors to elevate priorities in critical sectors and lead meetings between industry and government. They will work to amplify the voice of industry on international trade and investment issues and emphasise the critical role that businesses can play in strengthening democratic institutions and combatting the global pandemic.

“The US-India Business Council is a vital link between the two business communities and a proven facilitator of a productive dialog between the US and Indian Governments,” said Knight. 

Mazumdar-Shaw stated, “USIBC has been committed to enhancing US-India bilateral trade and in my new role, I look forward to forging collaborative initiatives in pharma & healthcare in the area of research, innovation and skill development between our two nations.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account






Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls